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Abstract
Summary In exploring relationships between vitamin D status
in childhood and cortical bone, little relationship was
observed with plasma concentrations of 25-hydroxyvitamin-
D2 [25(OH)D2], whereas 25-hydroxyvitamin-D3 [25(OH)D3]
was positively related to cortical bone mineral content
(BMCC) and cortical thickness, suggesting D3 exerts a
beneficial effect on cortical bone development in contrast
to D2.
Introduction The study is aimed to determine whether
vitamin D status in childhood is related to cortical bone
development by examining prospective relationships be-
tween plasma concentrations of 25(OH)D2 and 25(OH)D3
at 7.6, 9.9 or 11.8 years and peripheral quantitative
computed tomography (pQCT) measurements of the mid-
tibia at age 15.5 years, in children from the Avon
Longitudinal Study of Parents and Children.
Methods Relationships between vitamin D status and
pQCT outcomes were analysed by bootstrap linear regres-
sion, adjusted for age, sex, body composition, socioeco-
nomic position and physical activity, in 2,247 subjects in
whom all covariates were available. 25(OH)D3 was also
adjusted for season and 25(OH)D2, and 25(OH)D2 for
25(OH)D3.
Results 25(OH)D3 was positively related to BMCC [0.066
(0.009,0.122), P=0.02], whereas no association was seen
with 25(OH)D2 [−0.008(−0.044,0.027), P=0.7] [beta (with
95% CI) represents SD changes per doubling of vitamin D],
P=0.03 for difference in associations of 25(OH)D2 and 25
(OH)D3 with BMCC. There were also differences in
associations with cortical geometry, since 25(OH)D3 was
positively related to cortical thickness [0.11(0.04, 0.19), P=
0.002], whereas no association was seen with 25(OH)D2
[−0.04(−0.08,0.009), P=0.1], P=0.0005 for difference.
These relationships translated into differences in biome-
chanical strength as reflected by buckling ratio, which was
positively related to 25(OH)D2 [0.06(0.01,0.11), P=0.02]
indicating less resistance to buckling, but inversely related
to 25(OH)D3 [−0.1(−0.19,-0.02), P=0.03], P=0.001 for
difference.
Conclusions In contrast to 25(OH)D2, 25(OH)D3 was
positively related to subsequent cortical bone mass and
predicted strength. In vitamin D-deficient children in whom
supplementation is being considered, our results suggest
that D3 should be used in preference to D2.
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Introduction
Severe vitamin D deficiency, caused by reduced sun
exposure, leads to osteomalacia (adults)/rickets (children)
resulting from defective skeletal mineralisation. Milder
vitamin D deficiency, termed ‘insufficiency’, may also
affect skeletal health in the elderly by reducing bone
mineral density (BMD) and increasing fracture risk due to
secondary hyperparathyroidism, in the absence of mineralisa-
tion defects [1]. If also applicable in childhood, vitamin D
requirements in children would need to be set to prevent
insufficiency rather than vitamin D deficiency and rickets
[2]. Vitamin D insufficiency in children may be relatively
common. For example, in Maine, USA, 48% of girls aged 9–
11 had a total 25-hydroxyvitamin D (25(OH)D) level below
the 50 nmol l-1 (20 ng ml-1) cutoff commonly used to
indicate D insufficiency at least once over 3 years [3].
To ensure adequate vitamin D status, recommended
dietary allowances of vitamin D have recently been
proposed across different age groups including children
[4]. However, a recent Cochrane review concluded that
vitamin D supplementation in healthy children had limited
effects, but more trials are required to confirm the efficacy
of supplementation in deficient children [5]. Whereas three
studies in children reported modest improvements in bone
outcomes following treatment with cholecalciferol (D3) [6–
8], ergocalciferol (D2) was without effect in one study [9].
A possible explanation is that D2 may be less potent than
D3, since D3 and its metabolites have a higher affinity than
D2 for hepatic 25-hydroxylase and vitamin D receptors
[10]. Furthermore, in one such study, effects of D3
supplementation on BMD were suggested to be due to
changes in lean mass [6], consistent with observations that
levels of vitamin D metabolites and sunlight exposure are
related to height and body composition [11–13], which are
in turn strongly related to bone parameters [14].
Observational studies of the relationship between plasma
concentration of total 25(OH)D and bone outcomes in
childhood have yielded conflicting findings [15–17]. These
differences may have arisen from confounding, which is
difficult to adjust based on results of total 25(OH)D levels,
since D2 and D3 are derived from different sources. For
example, as the majority of D3 is derived from skin
synthesis following the action of UVR, 25(OH)D3 levels
are affected by factors influencing sun exposure such as
outdoor physical activity which is known to affect bone
development [18]. Whereas dietary fish intake and fortifica-
tion of certain foods contribute to D3, D2 is mainly derived
from fungi, plants and dietary supplements, implying that
dietary patterns affect levels of 25-hydroxyvitamin-D2 [25
(OH)D2] and, to a lesser extent, 25-hydroxyvitamin-D3 [25
(OH)D3]. This represents another source of confounding
since dietary patterns may affect bone development [19],
possibly through coassociation with socioeconomic position
(SEP) which is also related to bone development in
childhood [20].
We examined whether vitamin D status influences
cortical bone development in childhood, based on 25(OH)
D2 and 25(OH)D3 concentrations measured at age 7.6, 9.9
or 11.8, and results of peripheral quantitative computed
tomography (pQCT) scans of the mid-tibia performed at
age 15.5, in the Avon Longitudinal Study of Parents and
Children (ALSPAC). Specifically, we wished to determine
(i) whether vitamin D status is related to subsequent cortical
bone development, (ii) to what extent are its associations
which we find are independent of confounders including
physical activity and body composition (based on contem-
poraneous measures of fat and lean mass by DXA), and (iii)
whether there is any evidence that 25(OH)D3 has stronger
associations with cortical bone development than 25(OH)
D2, suggesting supplementation regimes based on D3 are
likely to be more effective compared to those using D2.
Methods
Study population
All pregnant women resident within a defined part of the
former county of Avon in South West England with an
expected date of delivery between April 1991 and December
1992 were eligible for recruitment, of whom 14,451 were
enrolled [21] (http://www.alspac.bristol.ac.uk). Written in-
formed consent was provided by the mothers, and informed
assent was obtained from the children at the time of
assessment. Ethical approval was obtained from the
ALSPAC Law and Ethics Committee (internal) and the
Central and South Bristol Research Ethics Committee
(external). Data in ALSPAC is collected by self-completion
postal questionnaires sent to main caregivers and the children
themselves, by abstraction from medical records, and from
examination of the children at research clinics. All children
with available data were included in the analyses.
Blood measurements
The primary exposures for this study were circulating
concentrations of 25(OH)D2 and 25(OH)D3 as measured on
nonfasting blood samples collected at the age 9.9 research
clinic. If no samples were available from the 9.9 clinic,
samples from the 11.8 clinic were used, or from the age
7.6 year clinic if neither the 9.9 or 11.8 were available.
Following collection samples were immediately spun,
frozen and stored at −80°C. Assays were performed in
2010 after a maximum of 12 years in storage with no
previous freeze–thaw cycles during this period. 25(OH)D2,
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25(OH)D3 and deuterated internal standard were extracted
from serum samples, following protein precipitation, using
Isolute C18 solid phase extraction cartridges. Potential
interfering compounds were removed by initial elution with
50% methanol followed by elution of the vitamins using
10% tetrahydrofuran in acetonitrile. Dried extracts were
reconstituted prior to injection into a high performance
liquid chromatography tandem mass spectrometre in the
multiple reaction mode (MRM). The MRM transitions (m/z)
used were 413.2>395.3, 401.1>383.3 and 407.5>107.2 for
25(OH)D2, 25(OH)D3 and hexa-deuterated(OH)D3, respec-
tively. Coefficients of variation (CVs) for the assay were
<10% across a working range of 1 to 250 ng ml-1 for both 25
(OH)D2 and 25(OH)D3. Intact parathyroid hormone [iPTH
(1–84)] [1] was measured by electrochemiluminescence
immunoassay on an Elecsys 2010 immunoanalyzer (Roche,
Lewes, UK). Inter-assay CV was less than 6% from 2 to 50
pmol l-1. The assay sensitivity (replicates of the zero
standard) was 1 pmol l-1.
pQCT variables
At the age 15.5 research clinic, pQCT scans at the 50%
mid-tibia were also performed using the Stratec XCT2000L
(Stratec, Pforzheim, Germany). Cortical bone area, cortical
bone mineral content (BMCC), cortical bone mineral
density (BMDC), periosteal circumference, endosteal cir-
cumference and cortical thickness were recorded. Strength
parametres comprised section modulus, cross-sectional
moment of inertia, strength strain index and buckling ratio.
A density of >650 mg cm-3 was used to define cortical
bone. Endosteal and periosteal circumference were derived
using a circular ring model. 4502 pQCT scans were
performed, of which 88 were excluded due to major motion
artifacts. Coefficients of variation for pQCT scans, based on
139 subjects scanned a mean of 31 days apart, were 2.7%,
1.3% and 2.9% for BMCC, BMDC and cortical bone area,
respectively.
Other variables
At 15.5 years research clinics, standing height (mm) was
measured using the Harpenden Stadiometer (Holtain,
Crymych, Wales, UK), and weight using the Tanita Body
Fat Analyzer (model TBF 305; Tanita, Arlington Heights,
IL, USA). Whole body DXA scans were performed using a
Lunar Prodigy scanner with paediatric scanning software
(GE Lunar Prodigy, Madison, WI, USA), providing
measures of total body fat and lean mass. Maternal SEP
was recorded at 32 weeks gestation by questionnaire and
categorised according to the Office of Population Censuses
and Surveys. Maternal education was assessed at the same
time by questionnaire. Pubertal stage was assessed using a
Tanner stage (pubic hair domain) questionnaire completed
at age 14.7 years [22]. Moderate and vigorous physical
activity was assessed by actigraph accelerometre at age 11,
and subsequently found to be related to BMD in ALSPAC
[23]. Date of birth and sex was obtained from birth
notification, and date of the scan was recorded automati-
cally, allowing age at scan to be calculated.
Statistical analyses
Descriptive statistics show means, standard deviation (SD),
medians and lower and upper quartiles. Analyses were
performed using seasonally adjusted 25 (OH)D3, which was
modelled according to date of blood sampling using linear
regression with trigonometric sine and cosine functions. 25
(OH)D3 was loge transformed to reduce heteroscedasticity.
The residual was used as the primary 25(OH)D3 exposure
variable in subsequent regression analyses. All analyses
were performed on standardised variables, i.e. subtracting the
mean and dividing by the SD. To include all participants on
whom a 25(OH)D2 was assayed, those with a value below
the detectable limit of the assay (0.5 ng ml-1) were assigned a
binary variable indicating whether an individual was at or
below the lower limit, which was used as a covariable in all
regression models. No individuals had 25(OH)D3 below the
detectable limit of the assay. Models were checked for
linearity by adding higher-order terms into the linear
predictor and by comparing the likelihood of nested models.
Further analyses were performed using a nonparametric
bootstrap procedure in conjunction with OLS linear
regression, based on 5,000 replications. Beta (β) estimates
and standard errors were calculated from the mean and SD
of the bootstrap distribution, respectively. All P values were
calculated using bootstrap means and standard errors,
compared to a Z-distribution and 95% percentile confidence
intervals calculated. Beta estimates were multiplied by
loge(2) and interpreted as per doubling in 25(OH)D2 or 25
(OH)D3. Estimates were calculated separately for males and
females, and the difference investigated using a bootstrap
Wald test. Combined (male and female) associations were also
investigated following adjustment for sex. The difference
between the effect of 25(OH)D2 and 25(OH)D3 was
calculated from the bootstrap replicate distribution, and the
P values using a Wald test.
Minimally adjusted analyses (model 1), which were based
on seasonally adjusted 25(OH)D3 levels or 25(OH)D2, were
adjusted for sex, age at pQCT scan, and adjusted for 25(OH)
D2 and seasonally adjusted 25(OH)D3, respectively. In
model 2, we additionally adjusted for loge-transformed
fat mass, lean mass and height. In the final model (model 3),
we also adjusted for physical activity and social economic
factors (maternal or paternal social class, maternal education).
Analyses with endosteal circumference were adjusted for
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periosteal circumference throughout (endosteal adjusted for
periosteal circumference). Sensitivity analyses were per-
formed based on model 2 by: (a) adjusting for parathyroid
hormone (PTH); (b) restricting those with available puberty
information and then, in this subgroup, examining the impact
of adjusting for pubertal status (tanner stages IV/V versus
earlier stages); and (c) restricting those with 25(OH)D assays
collected at age 9.9 years. All analyses were conducted using
STATA 11.2(College Station, TX, USA), and data is assumed
to be missing at random.
Results
Descriptive analyses
There were 1,709 boys and 1,870 girls with pQCT scans
(age 15.5 years), and plasma 25(OH)D2 and 25(OH)D3 (age
7.6, 9.9 or 11.8 years; see Fig. 1). Those who were included
in the analysis were of higher maternal and paternal social
class compared to those who were not. Boys were taller,
heavier and had greater lean mass compared to girls,
whereas fat mass was higher in girls (Table 1). BMCC,
cortical bone area, periosteal circumference, endosteal
circumference and cortical thickness were greater in boys
compared to girls, whereas BMDC was higher in girls. 25
(OH)D3 levels were slightly higher in boys and 25(OH)D2
levels slightly higher in girls. PTH levels were slightly
higher in girls. There was evidence of weak inverse
associations between 25(OH)D2 and height LM and FM,
which appeared somewhat stronger in girls compared to
boys, e.g. P=0.06 for gender interaction test for association
with height (Table 2). There was little association between
25(OH)D3 and height, and LM P>0.75, and weak evidence
of an association with FM P=0.06. 25(OH)D3 was
inversely related to PTH, whereas no association was seen
for 25(OH)D2. There was a very weak association between
seasonally adjusted 25(OH)D3 and 25(OH)D2, r=−0.0298
P=0.155, excluding those subjects in whom 25(OH)D2 was
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Fig. 1 Summary of data
collection
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Associations between 25(OH)D concentrations and pQCT
variables
There was a weak inverse association between 25(OH)D2
and BMDC in both minimally and more fully adjusted
analyses, to a similar extent in boys and girls (Table 3). For
example, in boys and girls combined, in our most
completely adjusted model, a doubling in 25(OH)D2 was
associated with a 0.05SD decrease in BMDC. Whereas 25
(OH)D2 was unrelated to periosteal circumference in
minimally adjusted analyses, there was a weak positive
association in more fully adjusted models, to a similar
degree, in boys and girls. In minimally adjusted analyses,
25(OH)D2 was inversely related to cortical bone area,
BMCC, endosteal adjusted for periosteal circumference and
cortical thickness in females, but this was not seen after
more complete adjustment. There was a positive association
between 25(OH)D2 levels and buckling ratio in all models,
to a similar extent, in boys and girls (Table S1).
Positive associations were observed between 25(OH)D3
and cortical bone area and BMCC in anthropometry
adjusted and fully adjusted analyses (Table 4). In all
models, 25(OH)D3 was positively related to cortical
thickness and inversely related to endosteal adjusted for
periosteal circumference. For example, in our most fully
adjusted model, a doubling in 25(OH)D3 was associated
with a 0.11 SD increase in cortical thickness. There was
also an inverse association between 25(OH)D3 and buck-
Table 1 Descriptive statistics
[N (male)=1,709; N (female)=1,870]
Mean (SD) 25th 50th 75th
Age [year] Male 15.5 (0.26) 15.3 15.4 15.6
Female 15.5 (0.28) 15.3 15.4 15.6
Anthropometry Height [cm] Male 174.3 (7.5) 169.7 174.5 179.4
Female 164.8 (6.1) 160.7 164.7 168.6
Weight [kg] Male 63.5 (11.4) 56.0 61.9 69.3
Female 58.8 (10.3) 51.9 57.0 63.9
BMI [kg m-2] Male 20.8 (3.1) 18.8 20.2 22.2
Female 21.6 (3.5) 19.3 21.0 23.2
Fat mass-Total body [kg] Male 10.8 (7.8) 5.7 8.3 12.9
Female 18.6 (7.9) 13.2 17.1 22.1
Lean mass-Total body [kg] Male 49.8 (6.6) 45.7 49.9 54.1
Female 37.1 (3.9) 34.5 36.8 39.5
pQCT BMDC [mg cm-3] Male 1,074.2 (34.3) 1,053.1 1,077.1 1,099.2
Female 1,124.6 (22.3) 1,111.2 1,126.3 1,139.8
BAC [mm2] Male 329.1 (46.8) 297.1 329.3 359.6
Female 275.1 (36.6) 250.0 273.6 298.7
BMCC [mg] Male 353.8 (53.2) 318.8 353.7 388.3
Female 309.3 (41.0) 281.1 308.0 335.9
PC [mm] Male 76.2 (5.3) 72.8 76.1 79.6
Female 69.5 (4.9) 66.3 69.2 72.6
EC [mm] Male 40.9 (5.9) 37.1 40.4 44.1
Female 37.0 (5.4) 33.6 36.5 39.7
CT [mm] Male 5.63 (0.7) 5.2 5.7 6.1
Female 5.17 (0.6) 4.8 5.2 5.6
Plasma measures 25(OH)D3 [ng ml
-1] Male 24.1 (9.0) 18.1 23.0 28.5
Female 22.8 (8.2) 17.1 22.1 27.4
25(OH)D2 [ng ml
-1] Male 1.80 (1.9) 0.5 1.2 2.6
Female 1.89 (1.9) 0.5 1.4 2.7
PTH [pmol l-1] Male 4.53 (1.8) 3.2 4.2 5.5
Female 5.11 (2.3) 3.5 4.6 6.1
Table shows descriptive characteristics of anthropometric parametres, 50% tibia pQCT parametres, and plasma measures in males and females at
age 15.5 years. Statistics are presented as means, SDs, medians, and upper and lower quartiles
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ling ratio in both minimally and more fully adjusted
analyses (Table S2), suggesting a protective effect on the
skeleton since buckling ratio is inversely related to bone
strength. These associations tended to be stronger in boys,
in whom beta coefficients were two to three times higher
than in girls, and P values for gender-specific regression
equations were only below the P<0.05 significance
threshold in boys. However, formal gender interaction tests
were consistentlyP>=0.1, and so evidence that these
associations were stronger in boys compared to girls is
not compelling.
Subsequently, we compared associations between 25
(OH)D2 and pQCT parametres as shown in Table 3, with
associations between 25(OH)3 and pQCT parametres as
shown in Table 4. P values for differences in these
associations are shown in Table 5, for minimally and more
fully adjusted models. In the case of BMDC and cortical
bone area, there was weak evidence of a difference between
25(OH)D2 and 25(OH)D3 in fully adjusted models, P=0.1
and P=0.07, respectively, boys and girls combined (Table 5).
For BMCC, there was moderate evidence of a difference
between 25(OH)D2 and 25(OH)D3 P<0.05 in all models,
boys and girls combined. There was strong evidence of
difference between 25(OH)D2 and 25(OH)D3 in CT,
endosteal adjusted for periosteal circumference and BR, P<
0.001 in minimal and more completely adjusted models,
boys and girls combined. Apart from weak evidence of a
difference in girls in our anthropometry-adjusted model (P=
0.04), there was no evidence of a difference between 25(OH)
D2 and 25(OH)D3 with respect to periosteal circumference.
No difference was observed for any model in respect of
associations between 25(OH)D2 and 25(OH)D3 and cross-
sectional moment of inertia, section modulus and strength
strain index (results not shown).
Sensitivity analyses and exploration of additional models
In view of the biological relationship between vitamin D
status and PTH concentrations, we examined whether
associations between pQCT parametres and 25(OH)D
which we observed were mediated by PTH, but repeating
the above analyses including additional adjustment for PTH
did not affect the results (see Table S3 for results for
buckling ratio, anthropometry-adjusted analyses). In the
case of associations between 25(OH)D2 and buckling ratio,
β was attenuated by approximately 15% when restricting
analyses to those with complete puberty information, but no
further change was seen after adjusting for Tanner stage
within this subset. β for the association between 25(OH)D2
and buckling ratio increased by approximately 50% on
restricting analyses to subjects with blood samples at age
9.9, suggesting some associations may be strengthened
when vitamin D samples obtained a longer interval before
pQCT measurements are excluded. β values were very
similar across all groups for associations between 25(OH)
D3 and buckling ratio. We found no evidence of nonline-
Table 2 Associations between plasma concentration of 25(OH)D2 and 25(OH)D3 and anthropometry variables
Vitamin 25(OH)D2 Vitamin 25(OH)D3 P value
(D2D3)
Minimally adjusted, N=3,579 (males=1,709) Minimally adjusted, N=3,579 (males=1,709)
Beta 95% CI P value (sex) Beta 95% CI P value (sex)
Height Male −0.026 (−0.072, 0.021) 0.06 −0.070 (−0.169, 0.026) 0.04 0.42
Female −0.070 (−0.107, -0.028) 0.056 (−0.016, 0.131) 0.01
ALL −0.050 (−0.085, -0.011) 0.000 (−0.061, 0.061) 0.17
Lean mass Male −0.021 (−0.059, 0.017) 0.17 −0.027 (−0.112, 0.060) 0.22 0.90
Female −0.040 (−0.073, -0.017) 0.034 (−0.012, 0.081) 0.01
ALL −0.030 (−0.063, -0.006) 0.007 (−0.040, 0.054) 0.14
Fat mass Male −0.017 (−0.066, 0.031) 0.30 −0.048 (−0.160, 0.066) 0.72 0.61
Female −0.040 (−0.081, -0.001) −0.070 (−0.140, -0.003) 0.44
ALL −0.030 (−0.069, 0.007) −0.060 (−0.124, 0.002) 0.40
Ln PTH Male −0.010 (−0.064, 0.045) 0.55 −0.260 (−0.367, -0.148) 0.65 0.01
Female −0.026 (−0.076, 0.024) −0.290 (−0.392, -0.189) 0.01
ALL −0.019 (−0.064, 0.027) −0.270 (−0.346, -0.200) 0.01
Table shows associations between plasma concentration of 25(OH)D2 and 25(OH)D3 and height, total body lean mass, loge fat mass and loge
parathyroid hormone (PTH), adjusted for sex, age at scan and 25(OH)D3 and 25(OH)D2 respectively, in 1709 males and 1870 females at age
15.5 years. Beta coefficients represent SD change in height, lean mass, loge fat mass, and loge PTH, per doubling of vitamin 25(OH)D2 and 25
(OH)D3. 95% confidence intervals are presented for beta coefficients, P value (sex) shows the difference in associations between males and
females, and P value (D2D3) is the probability of a difference in associations between 25(OH)D2 and 25(OH)D3
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arity of associations between either seasonally adjusted 25
(OH)D3 or 25(OH)D2 in any of the models fitted.
Discussion
We report by far the largest prospective cohort study of
relationships between vitamin D status in childhood and
subsequent cortical bone outcomes. 25(OH)D3 was posi-
tively related to BMCC as measured by pQCT approxi-
mately 5 years later, which appeared to be secondary to an
increase in CT. This association between 25(OH)D3 and
cortical thickness resulted from a decrease in endosteal
expansion, since 25(OH)D3 showed an equivalent inverse
association with endosteal adjusted for periosteal circum-
ference. This relationship may also have led to greater
biomechanical strength, in view of the inverse association
observed between 25(OH)D3 and buckling ratio. The latter
relationship may have implications in terms of reduced
fracture risk in later life, based on associations between
buckling ratio as measured at the hip in elderly populations,
and subsequent risk of hip fracture [24, 25]. The effect sizes
that we observed were similar in magnitude to that of other
important external influences on skeletal development such
as fat mass, which we have previously reported to influence
cortical bone development [14]. In further analyses, based
on the same study sample, we found that a doubling in fat
mass was associated with a 0.13 SD increase in cortical
thickness (analyses adjusted for age and height), which was
similar to that seen for 25(OH)D3, of which a doubling was
associated with a 0.11 SD increase in cortical thickness.
Identification of 25(OH)D concentrations in childhood
associated with optimal outcomes for bone and other health
outcomes, and how these might translate into public health
recommendations, is a matter of controversy [26]. Argu-
ably, the finding that a doubling in 25(OH)D3 is associated
with a 0.11 SD increase in cortical thickness is not a strong
enough effect to justify widespread vitamin D supplemen-
tation in childhood. Since >25% of our study population
had insufficient total 25(OH)D based on the 20 ng ml-1
cutoff [26], this conclusion is likely to apply to other,
predominantly Caucasian, populations with a similarly high
prevalence of vitamin D insufficiency based on this
definition. This may represent a contrast with early life
exposure in utero, when vitamin D status has been
suggested to have major long-term influences on subse-
quent bone development including periosteal growth [27,
28]. On the other hand, 25(OH)D3 may have a stronger
Table 5 Differences between
associations of plasma concen-
tration of 25(OH)D2 and 25
(OH)D3 with pQCT parametres
Table shows the P value for
differences between the associa-
tions of plasma concentration of
25(OH)D2 and 25(OH)D3 with
50% tibial pQCT parametres at
age 15.5 years (as shown in
Tables 3 and 4, respectively).
Results are also shown for the
following adjustments: mini-
mally adjusted=sex and age at
scan; anthropometry-
adjusted=minimally adjusted
+height, loge fat mass and lean
mass; anthropometry-, SES- and
PA-adjusted= anthropometry-
adjusted+maternal and paternal
social class, maternal education,
and physical activity. All results















BMDC Male 0.62 0.58 0.31
Female 0.11 0.08 0.16
All 0.19 0.14 0.10
BAC Male 0.25 0.05 0.07
Female 0.13 0.77 0.45
All 0.06 0.10 0.07
BMCC Male 0.22 0.03 0.03
Female 0.07 0.46 0.28
All 0.04 0.04 0.03
PC Male 0.77 0.98 0.53
Female 0.89 0.04 0.30
All 0.80 0.15 0.26
ECPC Male 0.01 0.01 0.01
Female 0.01 0.03 0.07
All 0.01 0.01 0.01
CT Male 0.02 0.01 0.01
Female 0.01 0.02 0.05
All 0.01 0.01 0.01
BR Male 0.03 0.03 0.01
Female 0.01 0.01 0.04
All 0.01 0.01 0.01
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association with cortical outcomes in certain subgroups, in
whom supplementation may be more justifiable. For example,
beta coefficients were generally higher in boys, in whom a
doubling in 25(OH)D3 was associated with a 0.18 SD
increase in CT. Moreover, the magnitude of effects that we
observed may have been tempered by aspects of the study
design (see ‘Limitations’ below). Furthermore, whereas
observational studies of this nature provide some information
as to the likely benefits of vitamin D supplementation in
childhood, evidence from randomized controlled trials is
required before definitive conclusions can be drawn.
In those children in whom vitamin D supplementation is
being considered, an important question which follows is
which form of vitamin D is the most effective. In contrast to
the positive associations between 25(OH)D3 and cortical
bone outcomes described above, relationships with 25(OH)
D2 were null in the case of BMCC and cortical thickness.
Whereas a weak positive association was present between
25(OH)D2 and periosteal circumference, there was a weak
inverse association with BMDC, as well as a weak positive
association with buckling ratio suggesting reduced resis-
tance to buckling. Taken together, these findings suggest
that, in contrast to 25(OH)D3, 25(OH)D2, at these concen-
trations, is not associated with an overall benefit in terms of
future cortical bone development, which may have impor-
tant implications in terms of the choice of vitamin D
supplementation in childhood.
To our knowledge, no previous study has examined the
separate relationships between 25(OH)D2, 25(OH)D3 and
bone outcomes in childhood. Since 25(OH)D3 makes the
major contribution to total 25(OH)D, it is relevant to
compare our findings with those from these previous
studies based on total 25(OH)D. In a prospective study of
171 girls aged 9–15 years, total 25(OH)D was positively
associated with gains in femoral neck BMD over the
following 3 years which may have reflected an influence of
25(OH)D3 on cortical thickness as we observed [16]. On
the other hand, our findings contrast with those of a
previous study in which total 25(OH)D was found to be
positively related to BMDC of the radius and tibia in a
cross-sectional study based on 193 10- to 12-year-old girls
[15]. In terms of previous interventional studies, in a recent
study in 20 pairs of peripubertal female twins, D3 supple-
ments for 6 months led to an increase in tibial cortical bone
area due to reduced endosteal expansion as assessed by
pQCT [7]. In contrast, in a recent D2 supplementation trial
in 73 girls aged 12–14 years, no effect was observed on
pQCT parametres [9]. Although these findings are consis-
tent with our observation of an inverse association between
endosteal adjusted for periosteal circumference and 25(OH)
D3, but not 25(OH)D2, to our knowledge, no previous study
has directly compared the effect of administering these two
forms of vitamin D on cortical bone.
In terms of biological explanations for possible distinct
effects of 25(OH)D2 and 25(OH)D3 on bone, as suggested
by our results, indirect pathways via PTH may be involved.
Whereas 25(OH)D3 levels are known to be inversely
related to PTH, as confirmed here, an equivalent relation-
ship was not seen for 25(OH)D2, which is consistent with a
previous finding that a large dose of D3 decreased PTH in
the elderly, whereas D2 was without effect [29]. Any
tendency for 25(OH)D2 and 25(OH)D3 to differ in respect
of their relationships with PTH may be partly due to the
fact that D2 is less potent than D3: D3 and its metabolites
have a higher affinity than D2 for hepatic 25-hydroxylase
and vitamin D receptors; D3 is not directly metabolised to
24(OH)D as is D2; 25(OH)D2 has a lower affinity for
vitamin D binding protein compared to 25(OH)D3, leading
to faster metabolism and a shorter half life [10]. However,
adjusting our analyses for PTH did not attenuate the
observed association between 25(OH)D3 and endosteal
adjusted for periosteal circumference, suggesting that
differing relationships with PTH are unlikely to explain
the distinct associations between 25(OH)D2, 25(OH)D3 and
cortical bone parametres which we observed.
Alternatively, due to the observational nature of this
study, these different associations with 25(OH)D2 and 25
(OH)D3 may have arisen from confounding. For example,
25(OH)D3 levels are determined by sun exposure and diet
that may be affected by a range of factors including SEP
and outdoor physical activity, which may confound
relationships with bone outcomes. Although the association
between 25(OH)D3 and endosteal adjusted for periosteal
circumference was unaffected by adjusting for observed
measurements of these additional factors, unmeasured
confounders may be important. For example, D2 intake is
related to consumption of fruits and vegetables, which is
positively associated with childhood BMD as measured by
DXA [30]. In addition, fruit and vegetable intake is related
to a ‘prudent’ or ‘healthy’ diet [31], of which intake in
pregnancy is positively associated with BMD in subsequent
childhood [19].
Limitations
In terms of limitations of this study, our pQCT measure-
ments comprised a single slice, namely, the 50% mid-tibia,
which is unable to provide any information about trabecular
bone. In the study of 171 girls aged 9–15 years described
above, the relationship between baseline total 25(OH)D and
subsequent gain in BMD across puberty was particularly
strong at the lumbar spine [16] which is rich in trabecular
bone. Whereas the present study suggests that 25(OH)D
status has minimal effects on cortical bone, it may be that
stronger effects exist for trabecular bone which we were
unable to evaluate here. A further limitation is the relatively
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long interval between measurement of 25(OH)D and mea-
surement of cortical bone from pQCT scans, which may have
reduced the strength of associations observed between these
sets of parametres. Finally, the generalisability of our findings
is limited by the fact that the subset of 3,579 subjects forming
the basis of the present study is likely to differ in important
ways from the original cohort drawn from the general
population. For example, maternal social class in the subset
on which this paper is based was higher compared with those
who were not included (P=0.0001).
In conclusion, we found that in contrast to 25(OH)D2, 25
(OH)D3, as measured in childhood, was positively related
to BMCC, cortical thickness and resistance to buckling as
assessed 5 years later. These different associations suggest
that supplementation with vitamin D3 in childhood is likely
to prove more beneficial for subsequent cortical bone
development compared to vitamin D2, presumably reflecting
important differences between the actions of these two
isoforms on bone, the basis of which is currently unclear.
Interventional studies are justified in which effects of these
two forms of vitamin D are directly compared in the same
population, in order to test the conclusions from this
observational study, given that we are unable to exclude
confounding as a possible explanation for our findings.
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